SME campus (Part II) | Focus on diagnostics – AMR Conference

SME campus (Part II) | Focus on diagnostics

Moderation:

Betsy Wonderly Trainor, Alliance Manager, CARB-X

Speakers:

Colin Denver – CEO, SpeeDx

This content has been restricted to logged in users only. Please login to view this content.
Peter Haug – CFO & Co-Founder, Head of Business Development & Licensing, Noscendo GmbH
Piotr Gastrecki – CTO, Scope Fluidics

This content has been restricted to logged in users only. Please login to view this content.
Rosemarie Preyer – GenID GmbH
Doug Kwon, Scientific Co-founder, Day Zero Diagnostics & Associate Professor, Harvard Medical School

This content has been restricted to logged in users only. Please login to view this content.

Play Video

This might also be of interest for you:

News release, 16 June: SpeeDx and Roche Partner to Expand Access to Antibiotic Resistance Tests
News release, 14 May, Noscendo GmbH: Faster pathogen identification with new method
News release, 20 August: Scope Fluidics begins preparations for the accelerated registration procedure of the PCR|ONE SARS-CoV-2 panel in the USA
News release on the AID SARS-CoV-2 Detection Kit that allows a Real time PCR screening kit for the fast and sensitive detection of SARS-CoV-2 RNA, starting from swab material from the throat or nasopharynx as well as bronchoalveolar lavage
News release, 11 May: Day Zero Diagnostics Awarded $6.2 Million in CARB-X Funding for Development of New Technology to Rapidly Diagnose Superbug Infections and Determine the Most Effective Antibiotic for Treatment
CARB-X in the AMR Stakeholder Guide